Huda Salman
Clinical trials sponsored by Huda Salman, explained in plain language.
-
First-in-Human trial tests engineered 'Assassin' cells against aggressive blood cancers
Disease control Recruiting nowThis is an early-stage safety study for a new type of personalized cell therapy called CD4CAR. It is for adults and teens (12+) with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. Doctors will collect a patient's own immune cells, genetica…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Apr 03, 2026 14:49 UTC
-
New engineered cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing a new treatment called CD4CAR for adults with Chronic Myelomonocytic Leukemia (CMML) that has come back or not responded to standard care. Doctors will collect a patient's own immune cells, engineer them in a lab to target cancer cells, and infus…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Experimental cell therapy aims to bridge patients to Life-Saving transplant
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called CD4CAR for adults and teens with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to target the cancer, and infuse th…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC